Home›Search›Pharmacology and Clinical Pharmacy Research

Pharmacology and Clinical Pharmacy Research

Universitas Padjadjaran · Indonesia · Est. 2016

ISSN2527-7332eISSN2614-0020

✓ DOAJ✓ Open Access

/ 100

High Risk

Score Breakdown

✓ DOAJ Verified+15

Total15

H-Index

Total Works

195

Total Citations

286

2yr Mean Citedness

0.09

Free JIF alternative

Aims & Scope

The aim of PCPR is to to provide a forum for pharmacologists, clinical pharmacists, and other researchers to share the current update on pharmacology and best practice in clinical pharmacy. The editors therefore welcome contributions on the following topics: Experimental Pharmacology Clinical Pharmacology Molecular Pharmacology Toxicology Pharmacokinetics Pharmaceutical care Pharmacotherapy and evidence-based practice Pharmacoepidemiology and pharmacovigilance Pharmacoeconomy Other aspects of pharmacology and clinical pharmacy

General Information

Country / RegionIndonesia

Primary LanguageEnglish

1st Year Published2016

Frequencythree times a year

StatusActive (last: 2025)

Total Publications195

OA Since2015

Visit Journal Website

Submission Info

Peer ReviewAnonymous peer review

Review Time—

Acceptance Rate—

OA LicenseCC BY-SA

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

8/12 · 67%

✅

Do you know the journal / publisher?

Universitas Padjadjaran

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2527-7332 / 2614-0020

✅

Indexed in a trusted database?

DOAJ

✅

Peer review process documented?

Anonymous peer review

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.